Study of Innovative Strategies for Mitral Valve Repair
- Conditions
- Congenital Mitral Insufficiency
- Interventions
- Procedure: 3-steps standardized repair-oriented strategy
- Registration Number
- NCT06037447
- Lead Sponsor
- China National Center for Cardiovascular Diseases
- Brief Summary
The goal of this observational study is to compare the safety and effectiveness of a 3-steps standardized repair-oriented strategy with annuloplasty only in pediatric patients with mild to moderate mitral valve regurgitation.
The main questions it aims to answer are:
* Can 3-steps standardized repair-oriented strategy improve both left ventricular and mitral valve function in pediatric patients with mild to moderate mitral valve regurgitation?
* Can surgical complications caused by the 3-steps standardized repair-oriented strategy be non-inferior (clinically acceptable) to annuloplasty only? Participants will be assigned to either the Standardized Group (including subvalvular apparatus rehabilitation (leaflet plication if chordae absent on leaflet margin, mal-connected chordae resection if chordae mal-connected to leaflet body, papillary muscle splitting if short chordae or dysplastic or fused papillary muscle etc.), leaflets repair (leaflets plication if functional leaflet prolapse, leaflet cleft closure and patch augmentation for anatomical leaflet defect, etc.) and annuloplasty (posterior annuloplasty for annular dilatation and shallow leaflet coaptation, etc.)) or the Annuloplasty Group (annuloplasty only during mitral repair surgeries. Additionally, echocardiography, electrocardiograms, and measurements of N-terminal pro-brain natriuretic peptide (NT-proBNP) were conducted before the initiation of surgery and at 1 months, 3 months, and 6 months after mitral repair.
Researchers will compare the Standardized Group and the Annuloplasty Group to see if the recurrence rate of moderate to severe mitral valve regurgitation, as assessed by echocardiography after 6 months of surgery, is lower in the former than in the latter.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 256
- < 14 years old
- had not undertake mitral valve surgery before
- moderate to severe mitral regurgitation
- moderate to severe mitral regurgitation which concommitant with other cardiac malformation which can not be correct or can only perform palliative surgery
- concommitant with mitral stenosis
- ischemic mitral regurgitation (for example, concommitant with anomalous origin of coronary artery)
- Barlow syndrome
- dysplasia of mitral leaflet
- complete/Partial endocardial cushion defect
- common atrioventricular valve
- atrioventricular common channel
- cardiomyopathy
- other mitral valve surgery contraindications
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Standardized Group 3-steps standardized repair-oriented strategy Patients in this group will undergo standardized strategy during mitral repair surgeries, including subvalvular apparatus rehabilitation, leaflets repair and annuloplasty.
- Primary Outcome Measures
Name Time Method the recurrence rate of moderate to severe mitral valve regurgitation after 6 months of surgery During follow-up visits, echocardiographic examination is conducted to measure the degree of mitral valve regurgitation. If it falls within the moderate to severe range, it is recorded as a recurrence.
- Secondary Outcome Measures
Name Time Method NT-proBNP level after 6 months of surgery The trend in NT-proBNP levels.
Improvement in symptoms after 6 months of surgery Based on patient and caregiver descriptions, if symptoms such as chest discomfort, shortness of breath, and delayed development show improvement following physical activity, it is recorded as an improvement in symptoms.
Change in left ventricular function after 6 months of surgery Based on the echocardiogram, measurements are taken for left ventricular end-diastolic diameter.
Incidence rate of surgical complications after 6 months of surgery Incidence rate of surgical complications, including infection, low cardiac output, arrhythmia, cardiac insufficiency, delayed sternal closure, thromboembolism and bleeding events, neurological complications(stroke, seizures and intracerebral hemorrhage).
Trial Locations
- Locations (1)
Fuwai hospital
🇨🇳Beijing, Beijing, China